Cas13b-mediated RNA targeted therapy alleviates genetic dilated cardiomyopathy in mice
Recent advances in gene editing technology have opened up new avenues for in vivo gene therapy, which holds great promise as a potential treatment method for dilated cardiomyopathy (DCM). The CRISPR-Cas13 syst...